GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound 13 [WO2021188450]
Compound class:
Synthetic organic
Comment: The chemical structure for this compound was obtained from WHO INN proposed list 134 (Feb 2026), in which it is described as a NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome inhibitor with potential as a non-steroidal anti-inflammatory agent. It is one of the structures claimed in Zomagen Biosciences' (now part of Eli Lilly via a previous Ventyx Biosciences merger) patent WO2021188450 [1]. Evidence suggests that abdenoflast is likely the INN for the peripherally restricted NLRP3 inhibitor VTX2735 [2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13981 | abdenoflast |
Synonyms ![]() |
| compound 13 [WO2021188450] |
Database Links ![]() |
|
| BindingDB Ligand | 50634195 |
| ChEMBL Ligand | CHEMBL5419019 |
| PubChem CID | 156857536 |
| Search Google for chemical match using the InChIKey | LQKIQSJLXCYGOX-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | LQKIQSJLXCYGOX |
| Search PubMed clinical trials | abdenoflast |
| Search PubMed titles | abdenoflast |
| Search PubMed titles/abstracts | abdenoflast |
| UniChem Compound Search for chemical match using the InChIKey | LQKIQSJLXCYGOX-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | LQKIQSJLXCYGOX-UHFFFAOYSA-N |